---
figid: PMC3174390__ijbsv07p1056g04
figtitle: Inhibitory role of Smad7 in renal fibrosis and inflammation
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
pmcid: PMC3174390
filename: ijbsv07p1056g04.jpg
figlink: /pmc/articles/PMC3174390/figure/F4/
number: F4
caption: Inhibitory role of Smad7 in renal fibrosis and inflammation. Overexpression
  of Smad7 prevents Smad2/3 from phosphorylation by degrading the TβRI as well as
  Smads via the ubiquitin degradation pathway (Ub), thereby inhibiting Smad3-dependent
  renal fibrosis in response to TGF-β1, AGEs, and angiotensin II (Ang II). In addition,
  overexpression of Smad7 can induce IκBα, an inhibitor of KF-κB, therefore inhibiting
  NF-κB-driven renal inflammation. Thus, Smad7 acts as a therapeutic agent for treatment
  of kidney diseases. Blue lines (symbols) indicate protective or negative regulation
  pathways, while red arrows (symbols) represent pathogenic or positive regulation
  pathways.
papertitle: Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation.
reftext: Hui Yao Lan. Int J Biol Sci. 2011;7(7):1056-1067.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9705946
figid_alias: PMC3174390__F4
figtype: Figure
redirect_from: /figures/PMC3174390__F4
ndex: 3f2f208b-dec8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3174390__ijbsv07p1056g04.html
  '@type': Dataset
  description: Inhibitory role of Smad7 in renal fibrosis and inflammation. Overexpression
    of Smad7 prevents Smad2/3 from phosphorylation by degrading the TβRI as well as
    Smads via the ubiquitin degradation pathway (Ub), thereby inhibiting Smad3-dependent
    renal fibrosis in response to TGF-β1, AGEs, and angiotensin II (Ang II). In addition,
    overexpression of Smad7 can induce IκBα, an inhibitor of KF-κB, therefore inhibiting
    NF-κB-driven renal inflammation. Thus, Smad7 acts as a therapeutic agent for treatment
    of kidney diseases. Blue lines (symbols) indicate protective or negative regulation
    pathways, while red arrows (symbols) represent pathogenic or positive regulation
    pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Agt
  - Tgfb1
  - Tnf
  - Il1b
  - Agtr1a
  - Agtr1b
  - Ager
  - Mok
  - Tgfbr1
  - Ephb1
  - Mapk14
  - Syt1
  - Smad7
  - Smad4
  - Smad3
  - Smad2
  - ANGPT2
  - VPS51
  - TGFB1
  - TNF
  - IL1B
  - AGTR1
  - ATM
  - SLC33A1
  - PGR-AS1
  - AGTR2
  - AGER
  - MOK
  - TGFBR2
  - TGFBR1
  - EPHB2
  - MAPK1
  - MAPK3
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - NFKBIA
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - SMAD7
  - SMAD4
  - SMAD3
  - SMAD2
  - Serpinb9d
  - Tgfbr2
  - Ephb2
  - Mapk1
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Rela
  - Gorasp1
---
